blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3431999

EP3431999 - METHOD FOR DETECTING AGGREGATE OF AGGREGATE-FORMING POLYPEPTIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.05.2024
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  23.06.2023
FormerGrant of patent is intended
Status updated on  21.05.2023
FormerRequest for examination was made
Status updated on  21.12.2018
FormerThe international publication has been made
Status updated on  22.09.2017
Most recent event   Tooltip31.05.2024No opposition filed within time limitpublished on 03.07.2024  [2024/27]
Applicant(s)For all designated states
Peoplebio, Inc.
242 Pangyo-ro, 6fl, PDC C-dong
Bundang-gu
Seongnam-si
13487 / KR
[2019/04]
Inventor(s)01 / LEE, Byoung Sub
301-504
32 Samdeok-ro 63beon-gil
Manan-gu
Anyang-si Gyeonggi-do 14027 / KR
02 / LEE, Kwan Soo
18-1 Sadang-ro
Dongjak-gu
Seoul 07027 / KR
03 / KIM, Shin Won
103-505
30-27 Gangseo-ro 45da-gil
Gangseo-gu
Seoul 07704 / KR
04 / LIM, Kun Taek
303-1002
70 Gyoha-ro
Paju-si Gyeonggi-do 10872 / KR
05 / KIM, Gwang Je
302 36 Geomam-ro
Seo-gu
Incheon 22704 / KR
06 / YU, Ji Sun
6-1007
18 Eonju-ro 146-gil
Gangnam-gu
Seoul 06057 / KR
 [2019/04]
Representative(s)Herrero & Asociados, S.L.
Edificio Aqua - Agustín de Foxá, 4-10
28036 Madrid / ES
[N/P]
Former [2019/04]Herrero & Asociados, S.L.
Cedaceros, 1
28014 Madrid / ES
Application number, filing date17767005.616.03.2017
[2019/04]
WO2017KR02858
Priority number, dateKR2016003153416.03.2016         Original published format: KR 20160031534
[2019/04]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2017160104
Date:21.09.2017
Language:KO
[2017/38]
Type: A2 Application without search report 
No.:EP3431999
Date:23.01.2019
Language:EN
[2019/04]
Type: B1 Patent specification 
No.:EP3431999
Date:26.07.2023
Language:EN
[2023/30]
Search report(s)International search report - published on:KR09.08.2018
(Supplementary) European search report - dispatched on:EP28.11.2019
ClassificationIPC:G01N33/58, G01N33/68, G01N33/50
[2019/04]
CPC:
G01N33/6896 (EP,US); G01N33/542 (EP); G01N33/54306 (US);
G01N2333/4709 (EP,US); G01N2800/2821 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]  
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR DETEKTION EINES AGGREGATS EINES AGGREGATBILDENDEN POLYPEPTIDS[2019/04]
English:METHOD FOR DETECTING AGGREGATE OF AGGREGATE-FORMING POLYPEPTIDE[2019/04]
French:PROCÉDÉ DE DÉTECTION D'UN AGRÉGAT D'UN POLYPEPTIDE FORMANT UN AGRÉGAT[2019/04]
Entry into regional phase21.09.2018Translation filed 
21.09.2018National basic fee paid 
21.09.2018Search fee paid 
21.09.2018Designation fee(s) paid 
21.09.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
21.09.2018Examination requested  [2019/04]
11.06.2020Amendment by applicant (claims and/or description)
22.05.2023Communication of intention to grant the patent
21.06.2023Fee for grant paid
21.06.2023Fee for publishing/printing paid
21.06.2023Receipt of the translation of the claim(s)
Opposition(s)29.04.2024No opposition filed within time limit [2024/27]
Fees paidRenewal fee
13.03.2019Renewal fee patent year 03
12.03.2020Renewal fee patent year 04
12.03.2021Renewal fee patent year 05
15.02.2022Renewal fee patent year 06
15.02.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ26.07.2023
HR26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
[2024/23]
Former [2024/20]HR26.07.2023
PL26.07.2023
RS26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
Former [2024/10]HR26.07.2023
PL26.07.2023
RS26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
Former [2024/09]NO26.10.2023
GR27.10.2023
IS26.11.2023
Former [2024/08]NO26.10.2023
GR27.10.2023
Documents cited:Search[I]WO2012149365  (UNIV NORTHWESTERN [US], et al) [I] 1-17 * paragraphs [0092] - [0094]; claims 59-61 *;
 [I]WO2013081946  (PLAXGEN INC [US], et al) [I] 1-17 * summary of the invention;; figure 9; example 8; claim 1 *;
 [I]US2013149700  (WEBER ALFRED [AT], et al) [I] 1-17 * paragraph [[0045]]; claims 1,6 *;
 [X]US2015276771  (MADASAMY SHANMUGAVEL [US]) [X] 1-17 * examples 2,3 *;
 [I]  - B. WOLOZIN ET AL, "Mechanisms of Neurodegenerative Disorders. Part 1: Protein Aggregates", ARCH. NEUROL., (20000101), vol. 57, pages 793 - 796, XP055050361 [I] 1-17 * page 793, column 2 - page 794, column 1 *
 [I]  - CONWAY K A ET AL, "Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease", NATURE MEDICINE, NATURE PUB. CO, NEW YORK, (19981101), vol. 4, no. 11, doi:10.1038/3311, ISSN 1078-8956, pages 1318 - 1320, XP002283512 [I] 1-17 * see introduction on p.1318 & "in vitro fibrilization" on p.1320 *

DOI:   http://dx.doi.org/10.1038/3311
 [T]  - SEONG SOO A. AN ET AL, "Dynamic changes of oligomeric amyloid [beta] levels in plasma induced by spiked synthetic A[beta]42", ALZHEIMER'S RESEARCH & THERAPY, (20171017), vol. 9, no. 1, doi:10.1186/s13195-017-0310-6, XP055609472 [T] * the whole document *

DOI:   http://dx.doi.org/10.1186/s13195-017-0310-6
International search[A]KR20110081330  (PEOPLEBIO INC [KR]) [A] 1-31 * See paragraphs [00191, [0026], [0043] and [0066]-[0068]. *;
 [A]US8026070  (AN SEONG SOO ALEXANDER [US], et al) [A] 1-31 * See the entire document. *;
 [A]KR101352849B  (NANOENTEK, INC.) [A] 1-31 * See the entire document. *;
 [A]KR20140069346  (AFFIRIS AG [AT]) [A] 1-31 * See claims 1 and 5; paragraphs [0053]-[0056]. *;
 [PA]KR20160067026  (PEOPLEBIO INC [KR]) [PA] 1-31* See the entire document. *
by applicantUS4816567
 US4908305
 US5143825
 US5374530
 US5498551
 US5831012
    - MASSIMO STEFANI et al., J. Mol. Med., (20030000), vol. 81, pages 678 - 699
    - RADFORD SE et al., Cell, (19990000), vol. 97, pages 291 - 298
    - SILVERMAN, J. et al., Nature Biotechnology, (20050000), vol. 23, no. 12, page 1556
    - ARNOUX B et al., Acta Crystallogr. D Biol. Crystallogr., (20020000), vol. 58, page 12524
    - NIXON, AE, Current opinion in drug discovery development, (20060000), vol. 9, no. 2, page 2618
    - KOHLER; MILSTEIN, Journal of Immunology, (19760000), vol. 6, pages 511 - 519
    - CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628
    - MARKS et al., J. Mol. Biol., (19910000), vol. 222, no. 58, pages 1 - 597
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.